Home About Us Products Clinical Trials Media Career Contact Us
 
CLINICAL TRIALS > INFINNIUM SIMPLE III
Infinnium®

SIMPLE III

Study Design
   Principal Investigator: Prof. D. S. Gambhir
   Title: To assess the safety and efficacy of Paclitaxel-Eluting Infinnium® Stent in "Real World Lesions" in patients with
   multivessel coronary artery disease requiring multivessel stenting.
   Design: Single center, Observational Registry with Clinical follow-up at 1, 6 and 12 months
   No. of Patients: 123
   Status: Completed
* Presented during TCT 2007 Symposium, Washington 
BASELINE DEMOGRAPHICS N (%)  
Hypertension 69 (56.1%)  
Diabetes 41 (33.3%)  
Smoking 16 (13.0%)  
Dyslipidemia 12 (9.7%)  
LESION CLASSIFICATION N (%)  
Type B2 205 (53.8%)  
Type C 97 (25.5%)  
MACE AT 1 YEAR F-UP N (%)  
MI 3 (2.4%)  
Death 7 (5.7%)  
            Cardiac 6 (4.9%)  
            Non-Cardiac 1 (0.8%)  
TLR / TVR 3 (2.4%)  
CABG 2 (1.6%)  
MACE 12 (9.7%)  
 
 
Home  |  About Us  |  Products  |  Clinical Trials  |  Media  |  Career  |  Contact Us  |  Sitemap  |  Privacy Policy
Sahajanand Medical Technologies Pvt. Ltd. - "Sahajanand Estate", Wakhariawadi, Nr. Dabholi Char Rasta, Ved Road, Surat - 395004 (Guj.), India
Tel: +91-261-2521251-58 Fax: +91-261-2520252 © Copyright 2008. All rights reserved. Last Update: 2008/05/14